Andrew Dunn, MD, MPH, SFHM, FACP
Learn more about subscription options.
Register Now for a free account.
Dunn A. In AF or VTE, warfarin dosing by genotype improved time in therapeutic range but not clinical outcomes. Ann Intern Med. 2014;160:JC9. doi: 10.7326/0003-4819-160-6-201403180-02009
Download citation file:
Published: Ann Intern Med. 2014;160(6):JC9.
Cardiology, Rhythm Disorders and Devices, Venous Thromboembolism.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only